Rabacfosadine succinate structure
|
Common Name | Rabacfosadine succinate | ||
---|---|---|---|---|
CAS Number | 1431856-99-3 | Molecular Weight | 644.61400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H41N8O10P | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Rabacfosadine succinateRabacfosadine (GS-9219) succinate, a novel proagent of the nucleotide analogue PMEG, is designed as a cytotoxic agent that preferentially targets lymphoid cells[1]. |
Name | butanedioic acid,ethyl (2S)-2-[[2-[2-amino-6-(cyclopropylamino)purin-9-yl]ethoxymethyl-[[(2S)-1-ethoxy-1-oxopropan-2-yl]amino]phosphoryl]amino]propanoate |
---|---|
Synonym | More Synonyms |
Description | Rabacfosadine (GS-9219) succinate, a novel proagent of the nucleotide analogue PMEG, is designed as a cytotoxic agent that preferentially targets lymphoid cells[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C25H41N8O10P |
---|---|
Molecular Weight | 644.61400 |
Exact Mass | 644.26800 |
PSA | 269.75000 |
LogP | 1.95310 |
GS-9219 succinate |
UNII-3L28LG748I |
L-Alanine,N,N'-(((2-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis-,diethyl ester,succinic acid salt (1:1) |